Evidence map›Paper›PMID 24466311›Full record

ArticlePloS one2014

Quantitative assessment of the influence of TP63 gene polymorphisms and lung cancer risk: evidence based on 93,751 subjects.

Liang Zhang, Xiao-Feng Wang, Yu-Shui Ma, Qing Xia, Feng Zhang, Da Fu, Yi-Chao Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Polymorphism in theAfrican health sciences · 2021
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Liang ZhangDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Xiao-Feng WangDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Yu-Shui MaDepartment of Nuclear Medicine, Shanghai 10th People's Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Qing XiaDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Feng ZhangDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Da FuDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China ; Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yi-Chao WangDepartment of Orthopaedics, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
Fudan University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral genome-wide association studies on lung cancer (LC) have reported similar findings of a new susceptibility locus, 3q28. After that, a number of studies reported that the rs10937405, and rs4488809 polymorphism in chromosome 3q28 has been implicated in LC risk. However, the studies have yielded contradictory results.

methodsPubMed, ISI web of science, EMBASE and the Chinese National Knowledge Infrastructure databases were systematically searched to identify relevant studies. Data were abstracted independently by two reviewers. A meta-analysis was performed to examine the association between rs10937405, rs4488809 polymorphism at 3q28 and susceptibility to LC. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Heterogeneity and publication bias were also tested.

resultsA total of 9 studies including 35,961 LC cases and 57,790 controls were involved in this meta-analysis. An overall random-effects per-allele OR of1.19 (95% CI: 1.14-1.25; P<10(-5)) and 1.19 (95% CI: 1.13-1.25; P<10(-5)) was found for the rs10937405 and rs4488809 polymorphism respectively. Similar results were also observed using dominant or recessive genetic model. After stratified by ethnicity, significant associations were found among East Asians (per-allele OR = 1.22, 95% CI: 1.17-1.27; P<10(-5)); whereas no significant associations were found among Caucasians for rs10937405. In the sub-group analysis by sample size, significantly increased risks were found for these polymorphisms in all genetic models. When analyzed according to histological type, the effects of rs10937405, and rs4488809 at 3q28 on the risk of lung cancer were significant mostly for lung adenocarcinoma.

conclusionsOur findings demonstrated that rs10937405-G allele and rs4488809-G allele might be risk-conferring factors for the development of lung cancer, especially for East Asian populations.

Indexed as

AdenocarcinomaHumansLung NeoplasmsMeta-Analysis as TopicPolymorphism, Single NucleotideRisk FactorsTranscription FactorsTumor Suppressor ProteinsTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID24466311
PMCPMC3900682
OpenAlexW1980546536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.